methyl cinnamate has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; E, L; Hu, Y; Li, W; Yao, J; Zhou, X | 1 |
| Chen, L; Duan, S; Gui, Y; Li, A; Li, G; Tang, J | 1 |
2 other study(ies) available for methyl cinnamate and Disease Models, Animal
| Article | Year |
|---|---|
Methyl cinnamate protects against dextran sulfate sodium-induced colitis in mice by inhibiting the MAPK signaling pathway.
Topics: Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Mice; Mice, Inbred C57BL; Signal Transduction | 2023 |
Methyl cinnamate alleviated CCI-induced upregualtion of spinal AMPA receptors and pain hypersensitivity by targeting AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Cinnamates; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hyperalgesia; Male; Neuralgia; Phosphorylation; Pyrazoles; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Spinal Cord; Up-Regulation | 2018 |